Review
Genetics & Heredity
Prakash Amruth Raj Chukka, Stacey D. Wetmore, Nehal Thakor
Summary: Translational control plays a crucial role in dictating gene expression and altering physiological processes in eukaryotic cells. eIF5B plays a significant role in this process, especially in the survival and drug resistance of cancer cells.
FRONTIERS IN GENETICS
(2021)
Article
Oncology
Chengzhi Xu, Yupeng Shen, Yong Shi, Ming Zhang, Liang Zhou
Summary: This study reveals the role of EIF3B in head and neck squamous cell carcinoma (HNSCC) and identifies its promotion of CEBPB translation and IL6R expression. These findings provide important insights into the molecular basis and pathogenesis of HNSCC.
CANCER CELL INTERNATIONAL
(2022)
Article
Biotechnology & Applied Microbiology
Shaoran Song, Jie Liu, Miao Zhang, Xiaoqian Gao, Wei Sun, Peijun Liu, Yaochun Wang, Juan Li
Summary: The expression of the EIF3 gene family is associated with prognosis in breast cancer and may serve as a therapeutic target.
Article
Environmental Sciences
Cao Zhaohui, Tang Cifei, Huang Di, Zeng Weijia, Han Cairui, Li Zecong, Hu Xiaobo
Summary: In this study, it was found that cadmium exposure induced cell death in HepG2 cells via a ROS-mediated PERK-CHOP-related apoptotic signaling pathway, providing a novel insight into the mechanisms of cadmium-induced hepatotoxicity. Inhibitors targeting oxidative stress and ER stress might be potential strategies for preventing or treating this disorder.
ENVIRONMENTAL TOXICOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Patrick Senechal, Francis Robert, Regina Cencic, Akiko Yanagiya, Jennifer Chu, Nahum Sonenberg, Marilene Paquet, Jerry Pelletier
Summary: The translation initiation factor eIF4F is crucial for cap-dependent protein synthesis initiation. Different subunits of eIF4F have varying roles in development and tumorigenesis, with some being essential for viability and tumor onset, while others have non-essential functions. This study highlights the complex roles of different eIF4F subunits in gene expression regulation during embryogenesis and tumor development.
CELLULAR AND MOLECULAR LIFE SCIENCES
(2021)
Article
Cell Biology
Sonam Gupta, Amit Mishra, Sarika Singh
Summary: The study demonstrated that salubrinal provided significant protection against rotenone-induced adverse effects on dopaminergic neurons, suggesting its potential therapeutic utility in Parkinson's disease by attenuating progressive neuronal death and pathological alterations.
CELLULAR SIGNALLING
(2021)
Article
Multidisciplinary Sciences
Tea Lenarcic, Moritz Niemann, David J. F. Ramrath, Salvatore Calderaro, Timo Fluegel, Martin Saurer, Marc Leibundgut, Daniel Boehringer, Celine Prange, Elke K. Horn, Andre Schneider, Nenad Ban
Summary: This study investigates the assembly of the mitochondrial small subunit (mt-SSU) and identifies several assembly factors that interact with specific regions of rRNA to ensure proper assembly. The researchers use cryoelectron microscopy to determine the structures of assembly intermediates and propose a stepwise assembly process involving ribosomal protein and assembly factor exchange.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2022)
Article
Pharmacology & Pharmacy
Qiuya Wu, Duanfang Zhou, Zhengze Shen, Bo Chen, Gang Wang, Lihong Wu, Limei Zhang, Xiaoli Li, Lie Yuan, Yuanli Wu, Na Qu, Weiying Zhou
Summary: VPS34-IN1 is a specific selective inhibitor of Class III Phosphatidylinositol 3-kinase (PI3K) and has been shown to exhibit a significant antitumor effect in leukemia and liver cancer. In this study, the researchers focused on the anticancer effect and potential mechanism of VPS34-IN1 in estrogen receptor positive (ER+ ) breast cancer. The results showed that VPS34-IN1 inhibited the viability of ER+ breast cancer cells by inducing apoptosis through the activation of the PERK/ATF4/CHOP pathway of ER stress. These findings provide new insights and potential treatment strategies for ER+ breast cancer.
BIOCHEMICAL PHARMACOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Su Wu, Gerhard Wagner
Summary: eIF4F plays diverse roles in human cancers, with overexpression of EIF4G1 being more selective than EIF4E, serving as a prognostic indicator in cancer patients. This expression imbalance affects housekeeping pathways and cancer-related pathways, leading to cap-independent initiation due to eIF4G1 hyperphosphorylation. These findings provide a novel model of dysregulated eIF4F function and highlight the clinical relevance of cap-(in)dependent initiation in cancer.
Article
Biochemistry & Molecular Biology
Zhaohui Cao, Zhuan Wu, Tingting Duan, Cifei Tang, Di Huang, Xiaobo Hu
Summary: This study found that curcumin improves oxidative stress-induced apoptosis in pancreatic beta cells by inhibiting the PERK-CHOP pathway of ER stress. Curcumin acts by activating SIRT1 expression and reducing the expression of CHOP. These findings suggest that curcumin and SIRT1 may serve as a potential therapeutic approach for T1DM.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA
(2022)
Article
Oncology
Angela Rubio, Gavin D. Garland, Aristeidis Sfakianos, Robert F. Harvey, Anne E. Willis
Summary: Abnormalities in RNA binding proteins within the canonical translation factor machinery are associated with tumorigenesis and can be targeted for therapeutic purposes.
SEMINARS IN CANCER BIOLOGY
(2022)
Article
Chemistry, Medicinal
Xintao Gao, Yonglong Jin, Wenyong Zhu, Xiaochen Wu, Jing Wang, Chuanlong Guo
Summary: eIF4E is a central regulator in cancer cell growth, but there are currently no clinically available eIF4E inhibitors. Interfering with eIF4E/eIF4G interactions may provide a new strategy for designing eIF4E inhibitors.
JOURNAL OF MEDICINAL CHEMISTRY
(2023)
Article
Biochemistry & Molecular Biology
Paul Powell, Usha Bhardwaj, Dixie Goss
Summary: This study identifies secondary structures that selectively interact with eIF3 and explores its role in translation initiation of BYDV. The findings propose a new model for BYDV translation initiation and expand the known functionality of eIF3.
NUCLEIC ACIDS RESEARCH
(2022)
Article
Cell Biology
Xiaoxi Li, Jian Zheng, Shi Chen, Fan-dong Meng, Jing Ning, Shu-lan Sun
Summary: Chemotherapeutic agents, including the cardiac glycoside oleandrin, have been shown to induce immunogenic cell death (ICD) in breast cancer cells, enhancing anti-tumor immune responses. Oleandrin treatment triggered ICD in breast cancer cells by inducing calreticulin exposure and release of HMGB1, HSP70/90, and ATP. Mechanistically, oleandrin induced ER stress-associated, caspase-independent ICD mainly through the PERK/elF2 alpha/ATF4/CHOP pathway, suggesting its potential in combination with immune checkpoint inhibitors to improve immunotherapy efficacy.
CELL DEATH & DISEASE
(2021)
Article
Biochemistry & Molecular Biology
Zhaolin Gao, Min Li, Fei Yao, Xiaobo Xia, Tianqi Duan, Jingzhuo Meng, Yanxia Huang, Ye He, Adonira Saro, Jufang Huang
Summary: The study investigated the effects and underlying mechanisms of valdecoxib on retinal ischemia-reperfusion injury and oxygen-glucose deprivation/recovery injury. The results showed that valdecoxib protected R28 cells by reducing cell apoptosis and exerted a protective effect on retinas by inhibiting retinal ganglion cell apoptosis. In addition, valdecoxib reversed the expression of certain proteins induced by glaucomatous model and the reversal was mediated by the PERK-ATF4-CHOP pathway. These findings suggest that valdecoxib protects against glaucomatous injury by inhibiting ER stress-induced apoptosis via the PERK-ATF4-CHOP pathway.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)